Method for detecting coagulation in laser treatment of blood vessels

• US 6,766,187 B1
• Filed: 09/18/2000
• Issued: 07/20/2004
• Est. Priority Date: 09/18/2000
• Status: Expired due to Fees

• Current Assignee: ESC Medical Systems, Inc., Arizona Board of Regents (University of Arizona)
• Original Assignee: Lumenis Incorporated (Boston Scientific Corporation)
• Inventors: Black, John F., Barton, Jennifer K.
• Primary Examiner(s): Leung, Philip H.
• Application Number:
  US09/664,193
• Time in Patent Office: 1,401 Days
• Field of Search: 600/476, 600/473, 600/474, 600/475, 600/477, 600/479, 600/480, 600/500, 600/504, 600/505, 600/506
• US Class Current: 600/473
• CPC Class Codes: A61B 18/24 with a catheter A61B18/26, A61B18/28 take precedence
• CPC Class Codes: A61B 2017/00057 Light
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/0068 Confocal scanning

Abstract

Onset of coagulation of blood in a blood vessel irradiated by electromagnetic radiation is detected by directing light at the blood vessel and monitoring the intensity of a portion of the light remitted from the blood vessel. An increase or decrease in the monitored light intensity indicates the onset of coagulation. The increase or decrease results from the formation of methemoglobin in the blood which accompanies the onset of coagulation. The methemoglobin is formed by photo conversion or thermal conversion of normal blood oxyhemoglobin. The wavelength of the monitoring light is selected to be different from that of the electromagnetic radiation and is preferably a wavelength for which the ratio of its absorptivity in hemoglobin and its absorptivity in normal blood is less than about one-half or greater than about two.

Claims

1. A method of detecting onset of coagulation of blood in a blood vessel induced by irradiation of electromagnetic radiation, said electromagnetic radiation having a first wavelength, the method comprising the steps of:

(a) directing electromagnetic radiation having a second wavelength at the blood vessel, said second wavelength being different from said first wavelength;

(b) monitoring a portion of said second wavelength radiation remitted from the blood vessel; and

(c) interpreting one of an increase and decrease in said monitored remitted second wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

2. The method of claim 1, wherein said second wavelength is selected such that the absorptivity thereof in normal blood is greater than or equal to about two times the absorptivity thereof in methemoglobin, and wherein an increase in said monitored remitted second-wavelength radiation is interpreted as an indication of the onset of coagulation of blood in the blood vessel.

3. The method of claim 2, wherein said second wavelength is between about 525 and 585 nm.

4. The method of claim 1, wherein said second wavelength is selected such that the absorptivity thereof in normal blood is less than or equal to about one-half the absorptivity thereof in methemoglobin, and wherein a decrease in said monitored remitted second-wavelength radiation is interpreted as an indication of the onset of coagulation of blood in the blood vessel.

5. The method of claim 4, wherein said second wavelength is between about 610 and 660 nm.

6. The method of claim 4, wherein said second wavelength is between about 800 and 1000 nm.

7. A method of detecting onset of coagulation of blood in a blood vessel induced by irradiation of electromagnetic radiation, said electromagnetic radiation having a first wavelength, the method comprising the steps of:

(a) directing electromagnetic radiation having a second wavelength between about 610 nm and 660 nm at the blood vessel, said second wavelength being different from said first wavelength;

(b) monitoring a portion of said second wavelength radiation remitted from the blood vessel; and

(c) interpreting a decrease in said monitored remitted second wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

8. The method of claim 7, wherein said second wavelength is about 633 nm.

9. The method of claim 7, wherein said second wavelength is about 647 nm.

10. The method of claim 7, wherein said first wavelength is between about 485 and 590 nm.

11. The method of claim 7, wherein said second-wavelength radiation is CW radiation.

12. The method of claim 7, wherein said second-wavelength radiation is pulsed radiation.

13. A method of detecting onset of coagulation of blood in a blood vessel induced by irradiation of electromagnetic radiation, said electromagnetic radiation having a wavelength between about 485 and 590 nm, the method comprising the steps of:

(a) directing monitoring electromagnetic radiation having a wavelength between about 610 nm and 660 nm at the blood vessel;

(b) detecting a portion of said monitoring radiation remitted from the blood vessel; and

(c) interpreting a decrease in said detected remitted second-wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

14. The method of claim 13, wherein said monitoring radiation is CW radiation.

15. A method of detecting onset of coagulation of blood in a blood vessel irradiated by electromagnetic radiation, said electromagnetic radiation having a first wavelength, the method comprising the steps of:

(a) providing a source of electromagnetic radiation having a second wavelength between about 610 nm and 660 nm, said second wavelength being different from said first wavelength;

(b) providing a spatial filter having a transmitting aperture therein;

(c) focussing said second wavelength radiation on the blood vessel;

(d) focussing a portion of said second wavelength radiation remitted from said blood vessel into said transmitting aperture of said spatial filter;

(e) locating a detector relative to said transmitting aperture of said spatial filter for detecting remitted second wavelength radiation transmitted therethrough; and

(f) interpreting a decrease in said detected remitted second wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

16. The method of claim 15, wherein said second wavelength is about 633 nm.

17. The method of claim 15 wherein said second wavelength is about 647 nm.

18. The method of claim 15 wherein said first wavelength is between about 485 and 590 nm.

19. Apparatus for treating biological tissue by irradiation of the tissue with electromagnetic radiation having a first wavelength, the tissue to be treated including a blood vessel, the apparatus comprising:

a source of electromagnetic radiation having the first wavelength;

a first optical arrangement for directing first wavelength light from said source thereof to the biological tissue;

a source of electromagnetic radiation having a second wavelength different from the first wavelength;

a second optical arrangement for directing second wavelength light from said source thereof to the blood vessel in the biological tissue;

an optical detection arrangement for monitoring a portion of said second wavelength radiation remitted from the blood vessel; and

wherein said detection arrangement is arranged to interpret one of an increase and decrease in said monitored remitted second wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

20. The apparatus of claim 19, wherein said second wavelength is selected such that the absorptivity thereof in normal blood is greater than or equal to about two times the absorptivity thereof in methemoglobin, and wherein said detection arrangement interprets an increase in said monitored remitted second-wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

21. The apparatus of claim 19, wherein said second wavelength is selected such that the absorptivity thereof in normal blood is less than or equal to about one-half the absorptivity thereof in methemoglobin, and wherein said detection arrangement interprets a decrease in said monitored remitted second-wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

22. Apparatus for treating biological tissue by irradiation of the tissue with electromagnetic radiation having a first wavelength, the tissue to be treated including a blood vessel, the apparatus comprising:

a source of electromagnetic radiation having the first wavelength;

a first optical arrangement for directing first wavelength light from said source thereof to the biological tissue;

a source of electromagnetic radiation having a second wavelength between about 610 nm and 660 nm said second wavelength being different from said first wavelength;

a spatial filter having a transmitting aperture therein;

an optical system arrangement for focussing said second-wavelength radiation onto the blood vessel such that a portion of said focussed second-wavelength radiation is remitted from blood in said blood vessel, said optical system being further arranged for focussing a portion of said remitted portion of said second-wavelength into said transmitting aperture of said spatial filter;

a monitoring arrangement, said monitoring arrangement including a detector located relative to said transmitting aperture of said spatial filter for detecting remitted second-wavelength radiation transmitted therethrough; and

wherein said monitoring arrangement is arranged to interpret one of an increase and decrease in said monitored remitted second wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

23. The apparatus of claim 22, wherein said second wavelength is selected such that the absorptivity thereof in normal blood is greater than or equal to about two times the absorptivity thereof in methemoglobin, and wherein said detection arrangement interprets an increase in said monitored remitted second-wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.

24. The apparatus of claim 22 wherein said second wavelength is selected such that the absorptivity thereof in normal blood is less than or equal to about one-half the absorptivity thereof in methemoglobin, and wherein said detection arrangement interprets a decrease in said monitored remitted second-wavelength radiation as an indication of the onset of coagulation of blood in the blood vessel.